Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
Indexed incrossrefpubmed
Abstract
From New England Journal of Medicine, Bowles, L., Platton, S., Yartey, N., Dave, M., Lee, K., Hart, D.P., MacDonald, V., Green, L., Sivapalaratnam, S., Pasi, K.J. and MacCallum, P., Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19. New England Journal of Medicine DOI: 10.1056/NEJMc2013656. Copyright © 2020 Massachusetts Medical Society. Reprinted with permission.
Citation impact
500
total citations
- FWCI
- 11.83
- Percentile
- 100%
- References
- 6
Citations per year
Authors
11Topics & keywords
Topics
Keywords
- Lupus anticoagulant
- Partial thromboplastin time
- Medicine
- Coronavirus disease 2019 (COVID-19)
- Prothrombin time
- Coagulation testing
- Thromboplastin
- Systemic lupus erythematosus
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.